These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12890471)

  • 41. In silico sequence analysis of arylamine N-acetyltransferases: evidence for an absence of lateral gene transfer from bacteria to vertebrates and first description of paralogs in bacteria.
    Rodrigues-Lima F; Dupret JM
    Biochem Biophys Res Commun; 2002 May; 293(2):783-92. PubMed ID: 12054539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mdm20 protein functions with Nat3 protein to acetylate Tpm1 protein and regulate tropomyosin-actin interactions in budding yeast.
    Singer JM; Shaw JM
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7644-9. PubMed ID: 12808144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computational and experimental analyses of mammalian arylamine N-acetyltransferase structure and function.
    Walraven JM; Trent JO; Hein DW
    Drug Metab Dispos; 2007 Jun; 35(6):1001-7. PubMed ID: 17371801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crystal structure of arylamine N-acetyltransferases: insights into the mechanisms of action and substrate selectivity.
    Kubiak X; Dairou J; Dupret JM; Rodrigues-Lima F
    Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):349-62. PubMed ID: 23289949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of the human N(alpha)-acetyltransferase complex B (hNatB): a complex important for cell-cycle progression.
    Starheim KK; Arnesen T; Gromyko D; Ryningen A; Varhaug JE; Lillehaug JR
    Biochem J; 2008 Oct; 415(2):325-31. PubMed ID: 18570629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacogenetics of NAT: structural aspects.
    Pompeo F; Brooke E; Kawamura A; Mushtaq A; Sim E
    Pharmacogenomics; 2002 Jan; 3(1):19-30. PubMed ID: 11966400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of ARD1 variants in mammalian cells.
    Kim SH; Park JA; Kim JH; Lee JW; Seo JH; Jung BK; Chun KH; Jeong JW; Bae MK; Kim KW
    Biochem Biophys Res Commun; 2006 Feb; 340(2):422-7. PubMed ID: 16376303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physiological importance and identification of novel targets for the N-terminal acetyltransferase NatB.
    Caesar R; Warringer J; Blomberg A
    Eukaryot Cell; 2006 Feb; 5(2):368-78. PubMed ID: 16467477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-Terminal Acetylation by NatB Is Required for the Shutoff Activity of Influenza A Virus PA-X.
    Oishi K; Yamayoshi S; Kozuka-Hata H; Oyama M; Kawaoka Y
    Cell Rep; 2018 Jul; 24(4):851-860. PubMed ID: 30044982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The N-terminal acetyltransferase Naa10 is essential for zebrafish development.
    Ree R; Myklebust LM; Thiel P; Foyn H; Fladmark KE; Arnesen T
    Biosci Rep; 2015 Aug; 35(5):. PubMed ID: 26251455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two N-terminal acetyltransferases antagonistically regulate the stability of a nod-like receptor in Arabidopsis.
    Xu F; Huang Y; Li L; Gannon P; Linster E; Huber M; Kapos P; Bienvenut W; Polevoda B; Meinnel T; Hell R; Giglione C; Zhang Y; Wirtz M; Chen S; Li X
    Plant Cell; 2015 May; 27(5):1547-62. PubMed ID: 25966763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular basis for N-terminal alpha-synuclein acetylation by human NatB.
    Deng S; Pan B; Gottlieb L; Petersson EJ; Marmorstein R
    Elife; 2020 Sep; 9():. PubMed ID: 32885784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Arylamine N-acetyltransferases.
    Sim E; Westwood I; Fullam E
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):169-84. PubMed ID: 17428149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Arylamine N-acetyltransferase aggregation and constitutive ubiquitylation.
    Liu F; Zhang N; Zhou X; Hanna PE; Wagner CR; Koepp DM; Walters KJ
    J Mol Biol; 2006 Aug; 361(3):482-92. PubMed ID: 16857211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human NAA30 can rescue yeast mak3∆ mutant growth phenotypes.
    Drazic A; Varland S
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33600573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New links between protein N-terminal acetylation, dauer diapause, and the insulin/IGF-1 signaling pathway in Caenorhabditis elegans.
    Warnhoff K; Kornfeld K
    Worm; 2015; 4(2):e1023498. PubMed ID: 26435887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
    Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
    Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical evidence for relaxed substrate specificity of Nα-acetyltransferase (Rv3420c/rimI) of Mycobacterium tuberculosis.
    Pathak D; Bhat AH; Sapehia V; Rai J; Rao A
    Sci Rep; 2016 Jun; 6():28892. PubMed ID: 27353550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes.
    Sim E; Payton M; Noble M; Minchin R
    Hum Mol Genet; 2000 Oct; 9(16):2435-41. PubMed ID: 11005799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insight into cofactor recognition in arylamine N-acetyltransferase enzymes: structure of Mesorhizobium loti arylamine N-acetyltransferase in complex with coenzyme A.
    Xu X; Li de la Sierra-Gallay I; Kubiak X; Duval R; Chaffotte AF; Dupret JM; Haouz A; Rodrigues-Lima F
    Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):266-73. PubMed ID: 25664736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.